CRISPR and Cas Genes Market
CRISPR and Cas Genes Market Study by Vector-based Cas and DNA-free Cas for Genome Engineering, Disease Models, and Functional Genomes from 2023 to 2033
Analysis of CRISPR and Cas Genes Market Covering 30+ Countries Including Analysis of US, Canada, UK, Germany, France, Nordics, GCC countries, Japan, Korea and many more
Table of Content
1. Preface 1.1. Market Definition and Scope 1.2. Market Segmentation 1.3. Key Research Objectives 1.4. Research Highlights 2. Assumptions and Research Methodology 3. Executive Summary: Global Market 4. Market Overview 4.1. Introduction 4.1.1. Product Definition 4.1.2. Industry Evolution / Developments 4.2. Overview 4.2.1. Global Market Size (US$ Mn) Forecast, 2023–2033 4.2.2. Global Market Outlook 4.2.3. Evolution of CRISPRs 4.2.4. Research institutes involved in CRISPR Research 4.2.5. CRISPR: Funding & Investment 4.2.6. Mergers and Acquisitions 4.3. Market Dynamics 4.3.1. Drivers 4.3.2. Restraints 4.3.3. Opportunities 5. Global Market Analysis and Forecasts, by Product 5.1. Introduction & Definition 5.2. Market Value Forecast, by Product, 2023–2033 5.2.1. Vector-based Cas 5.2.2. DNA-free Cas 5.3. Market Attractiveness, by Product 6. Global Market Analysis and Forecasts, by Application 6.1. Introduction & Definition 6.2. Market Value Forecast, by Application, 2023–2033 6.2.1. Genome Engineering 6.2.2. Disease Models 6.2.3. Functional Genomics 6.2.4. Knockdown/activation 6.2.5. Others 6.3. Market Attractiveness, by Application 7. Global Market Analysis and Forecasts, by End user 7.1. Introduction & Definition 7.2. Market Value Forecast, by End-user, 2023–2033 7.2.1. Biotechnology & Pharmaceutical Companies 7.2.2. Academic & Government Research Institutes 7.2.3. Contract Research Organizations 7.3. Market Attractiveness, by End-user 8. Global Market Analysis and Forecasts, by Region 8.1. Key Findings 8.2. Market Value Forecast, by Region 8.2.1. North America 8.2.2. Europe 8.2.3. Asia Pacific 8.2.4. Latin America 8.2.5. Middle East & Africa 8.3. Market Attractiveness, by Country/Region 9. North America Market Analysis and Forecast 9.1. Introduction 9.2. Market Value Forecast, by Product, 2023–2033 9.2.1. Vector-based Cas 9.2.2. DNA-free Cas 9.3. Market Value Forecast, by Application, 2023–2033 9.3.1. Genome Engineering 9.3.2. Disease Models 9.3.3. Functional Genomics 9.3.4. Knockdown/activation 9.3.5. Others 9.4. Market Value Forecast, by End-user, 2023–2033 9.4.1. Biotechnology & Pharmaceutical Companies 9.4.2. Academic & Government Research Institutes 9.4.3. Contract Research Organizations 9.5. Market Value Forecast, by Country, 2023–2033 9.5.1. U.S. 9.5.2. Canada 9.6. Market Attractiveness Analysis 9.6.1. By Product 9.6.2. By Application 9.6.3. By End-user 9.6.4. By Country 10. Europe Market Analysis and Forecast 10.1. Introduction 10.2. Market Value Forecast, by Product, 2023–2033 10.2.1. Vector-based Cas 10.2.2. DNA-free Cas 10.3. Market Value Forecast, by Application, 2023–2033 10.3.1. Genome Engineering 10.3.2. Disease Models 10.3.3. Functional Genomics 10.3.4. Knockdown/activation 10.3.5. Others 10.4. Market Value Forecast, by End-user, 2023–2033 10.4.1. Biotechnology & Pharmaceutical Companies 10.4.2. Academic & Government Research Institutes 10.4.3. Contract Research Organizations 10.5. Market Value Forecast, by Country/Sub-region, 2023–2033 10.5.1. Germany 10.5.2. U.K. 10.5.3. France 10.5.4. Spain 10.5.5. Italy 10.5.6. Rest of Europe 10.6. Market Attractiveness Analysis 10.6.1. By Product 10.6.2. By Application 10.6.3. By End-user 10.6.4. By Country/Sub-region 11. Asia Pacific Market Analysis and Forecast 11.1. Introduction 11.2. Market Value Forecast, by Product, 2023–2033 11.2.1. Vector-based Cas 11.2.2. DNA-free Cas 11.3. Market Value Forecast, by Application, 2023–2033 11.3.1. Genome Engineering 11.3.2. Disease Models 11.3.3. Functional Genomics 11.3.4. Knockdown/activation 11.3.5. Others 11.4. Market Value Forecast, by End-user, 2023–2033 11.4.1. Biotechnology & Pharmaceutical Companies 11.4.2. Academic & Government Research Institutes 11.4.3. Contract Research Organizations 11.5. Market Value Forecast, by Country/Sub-region, 2023–2033 11.5.1. Japan 11.5.2. China 11.5.3. India 11.5.4. Rest of Asia Pacific 11.6. Market Attractiveness Analysis 11.6.1. By Product 11.6.2. By Application 11.6.3. By End-user 11.6.4. By Country/Sub-region 12. Latin America Market Analysis and Forecast 12.1. Introduction 12.2. Market Value Forecast, by Product, 2023–2033 12.2.1. Vector-based Cas 12.2.2. DNA-free Cas 12.3. Market Value Forecast, by Application, 2023–2033 12.3.1. Genome Engineering 12.3.2. Disease Models 12.3.3. Functional Genomics 12.3.4. Knockdown/activation 12.3.5. Others 12.4. Market Value Forecast, by End-user, 2023–2033 12.4.1. Biotechnology & Pharmaceutical Companies 12.4.2. Academic & Government Research Institutes 12.4.3. Contract Research Organizations 12.5. Market Value Forecast, by Country/Sub-region, 2023–2033 12.5.1. Brazil 12.5.2. Mexico 12.5.3. Rest of Latin America 12.6. Market Attractiveness Analysis 12.6.1. By Product 12.6.2. By Application 12.6.3. By End-user 12.6.4. By Country/Sub-region 13. Middle East & Africa Market Analysis and Forecast 13.1. Introduction 13.2. Market Value Forecast, by Product, 2023–2033 13.2.1. Vector-based Cas 13.2.2. DNA-free Cas 13.3. Market Value Forecast, by Application, 2023–2033 13.3.1. Genome Engineering 13.3.2. Disease Models 13.3.3. Functional Genomics 13.3.4. Knockdown/activation 13.3.5. Others 13.4. Market Value Forecast, by End-user, 2023–2033 13.4.1. Biotechnology & Pharmaceutical Companies 13.4.2. Academic & Government Research Institutes 13.4.3. Contract Research Organizations 13.5. Market Value Forecast, by Country/Sub-region, 2023–2033 13.5.1. GCC Countries 13.5.2. South Africa 13.5.3. Rest of Middle East & Africa 13.6. Market Attractiveness Analysis 13.6.1. By Product 13.6.2. By Application 13.6.3. By End-user 13.6.4. By Country/Sub-region 14. Competition Landscape 14.1. Market Player - Competition Matrix (By Tier and Size of companies) 14.2. Market Share Analysis, by Company (2018) 14.3. Company Profiles (Details - Overview, Financials, Recent Developments, Strategy) 14.3.1. Synthego 14.3.1.1. Company Overview 14.3.1.2. Financial Overview 14.3.1.3. Product Portfolio 14.3.1.4. SWOT Analysis 14.3.1.5. Strategic Overview 14.3.2. Thermo Fisher Scientific, Inc. 14.3.2.1. Company Overview 14.3.2.2. Financial Overview 14.3.2.3. Product Portfolio 14.3.2.4. SWOT Analysis 14.3.2.5. Strategic Overview 14.3.3. GenScript 14.3.3.1. Company Overview 14.3.3.2. Financial Overview 14.3.3.3. Product Portfolio 14.3.3.4. SWOT Analysis 14.3.3.5. Strategic Overview 14.3.4. Addgene 14.3.4.1. Company Overview 14.3.4.2. Financial Overview 14.3.4.3. Product Portfolio 14.3.4.4. SWOT Analysis 14.3.4.5. Strategic Overview 14.3.5. Merck KGaA (Sigma-Aldrich) 14.3.5.1. Company Overview 14.3.5.2. Financial Overview 14.3.5.3. Product Portfolio 14.3.5.4. SWOT Analysis 14.3.5.5. Strategic Overview 14.3.6. Integrated DNA Technologies, Inc. 14.3.6.1. Company Overview 14.3.6.2. Financial Overview 14.3.6.3. Product Portfolio 14.3.6.4. SWOT Analysis 14.3.6.5. Strategic Overview 14.3.7. Transposagen Biopharmaceuticals, Inc. 14.3.7.1. Company Overview 14.3.7.2. Financial Overview 14.3.7.3. Product Portfolio 14.3.7.4. SWOT Analysis 14.3.7.5. Strategic Overview 14.3.8. OriGene Technologies, Inc. 14.3.8.1. Company Overview 14.3.8.2. Financial Overview 14.3.8.3. Product Portfolio 14.3.8.4. SWOT Analysis 14.3.8.5. Strategic Overview 14.3.9. New England Biolabs 14.3.9.1. Company Overview 14.3.9.2. Financial Overview 14.3.9.3. Product Portfolio 14.3.9.4. SWOT Analysis 14.3.9.5. Strategic Overview 14.3.10. Dharmacon, a Horizon Discovery Group Co. 14.3.10.1. Company Overview 14.3.10.2. Financial Overview 14.3.10.3. Product Portfolio 14.3.10.4. SWOT Analysis 14.3.10.5. Strategic Overview 14.3.11. Cellecta, Inc. 14.3.11.1. Company Overview 14.3.11.2. Financial Overview 14.3.11.3. Product Portfolio 14.3.11.4. SWOT Analysis 14.3.11.5. Strategic Overview 14.3.12. Agilent Technologies 14.3.12.1. Company Overview 14.3.12.2. Financial Overview 14.3.12.3. Product Portfolio 14.3.12.4. SWOT Analysis 14.3.12.5. Strategic Overview 14.3.13. Applied StemCell, Inc. 14.3.13.1. Company Overview 14.3.13.2. Financial Overview 14.3.13.3. Product Portfolio 14.3.13.4. SWOT Analysis 14.3.13.5. Strategic Overview
Don't Need a Global Report?
save 40%! on Country & Region specific reports
List Of Table
Table 01: Global Market Size (US$ Mn) Forecast, by Product, 2023–2033
Table 02: Global Market Size (US$ Mn) Forecast, by Application, 2023–2033
Table 03: Global Market Size (US$ Mn) Forecast, by End-user, 2023–2033
Table 04: Global Market Size (US$ Mn) Forecast, by Region, 2023–2033
Table 05: North America Market Size (US$ Mn) Forecast, by Country, 2023–2033
Table 06: North America Market Size (US$ Mn) Forecast, by Product Type, 2023–2033
Table 07: North America Market Size (US$ Mn) Forecast, by Application Type, 2023–2033
Table 08: North America Market Size (US$ Mn) Forecast, by End-user, 2023–2033
Table 09: Europe Market Size (US$ Mn) Forecast, by Country/Sub-region, 2023–2033
Table 10: Europe Market Size (US$ Mn) Forecast, by Product Type, 2023–2033
Table 11: Europe Market Size (US$ Mn) Forecast, by Application, 2023–2033
Table 12: Europe Market Size (US$ Mn) Forecast, by End-user, 2023–2033
Table 13: Asia Pacific Market Size (US$ Mn) Forecast, by Country/Sub-region, 2023–2033
Table 14: Asia Pacific Market Size (US$ Mn) Forecast, by Product Type, 2023–2033
Table 15: Asia Pacific Market Size (US$ Mn) Forecast, by Application Type, 2023–2033
Table 16: Asia Pacific Market Size (US$ Mn) Forecast, by End-user, 2023–2033
Table 17: Latin America Market Size (US$ Mn) Forecast, by Country/Sub-region, 2023–2033
Table 18: Latin America Market Size (US$ Mn) Forecast, by Product Type, 2023–2033
Table 19: Latin America Market Size (US$ Mn) Forecast, by Application Type, 2023–2033
Table 20: Latin America Market Size (US$ Mn) Forecast, by End-user, 2023–2033
Table 21: Middle East & Africa Market Size (US$ Mn) Forecast, by Country/Sub-region, 2023–2033
Table 22: Middle East & Africa Market Size (US$ Mn) Forecast, by Product, 2023–2033
Table 23: Middle East & Africa Market Size (US$ Mn) Forecast, by Application, 2023–2033
Table 24: Middle East & Africa Market Size (US$ Mn) Forecast, by End-user, 2023–2033
More Insights, Lesser Cost (-50% off)
Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR
List Of Figures
Figure 01: Global Market Size (US$ Mn) and Distribution, by Region, 2023 and 2033
Figure 02: Market Snapshot
Figure 03: Opportunity Map, 2022
Figure 04: Opportunity Map, 2022
Figure 05: Opportunity Map, 2022
Figure 06: Global Market Size (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2023–2033
Figure 07: Global Market Value Share, by Product, 2022
Figure 08: Global Market Value Share, by Application, 2022
Figure 09: Global Market Value Share, by End-user, 2022
Figure 10: Global Market Value Share, by Region, 2022
Figure 11: Global Market Value Share, by Product, 2023 and 2033
Figure 12: Global Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Vector-based Cas, 2023–2033
Figure 13: Global Market Revenue (US$ Mn) and Y-o-Y Growth (%), by DNA-free Cas, 2023–2033
Figure 14: Global Market Attractiveness Analysis, by Product, 2023–2033
Figure 15: Global Market Value Share, by Application, 2023 and 2033
Figure 16: Global Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Genome Engineering, 2023–2033
Figure 17: Global Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Disease Models, 2023–2033
Figure 18: Global Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Functional Genomics, 2023–2033
Figure 19: Global Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Contract Research Organizations, 2023–2033
Figure 20: Global Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Functional Genomics, 2023–2033
Figure 21: Global Market Attractiveness Analysis, by Application, 2023–2033
Figure 22: Global Market Value Share, by End-user, 2023 and 2033
Figure 23: Global Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Biotechnology & Pharmaceutical Companies, 2023–2033
Figure 24: Global Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Academic & Government Research Institutes, 2023–2033
Figure 25: Global Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Contract Research Organizations, 2023–2033
Figure 26: Global Market Attractiveness Analysis, by End-user, 2023–2033
Figure 27: Global Market Value Share, by Region, 2023 and 2033
Figure 28: Global Market Attractiveness Analysis, by Region, 2023–2033
Figure 29: North America Market Size (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2023–2033
Figure 30: North America Market Value Share, by Country, 2023 and 2033
Figure 31: North America Market Attractiveness, by Country, 2023–2033
Figure 32: North America Market Value Share, by Product Type, 2023 and 2033
Figure 33: North America Market Attractiveness, by Product Type, 2023–2033
Figure 34: North America Market Value Share, by Application Type, 2023 and 2033
Figure 35: North America Market Attractiveness, by Application Type, 2023–2033
Figure 36: North America Market Value Share, by End-user, 2023 and 2033
Figure 37: North America Market Attractiveness, by End-user, 2023–2033
Figure 38: Europe Market Size (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2023–2033
Figure 39: Europe Market Value Share, by Country/Sub-region, 2023 and 2033
Figure 40: Europe Market Attractiveness, by Country/Sub-region, 2023–2033
Figure 41: Europe Market Value Share, by Product Type, 2023 and 2033
Figure 42: Europe Market Attractiveness, by Product Type, 2023–2033
Figure 43: Europe Market Value Share, by Application, 2023 and 2033
Figure 44: Europe Market Attractiveness, by Application, 2023–2033
Figure 45: Europe Market Value Share, by End-user, 2023 and 2033
Figure 46: Europe Market Attractiveness, by End-user, 2023–2033
Figure 47: Asia Pacific Market Size (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2023–2033
Figure 48: Asia Pacific Market Value Share, by Country/Sub-region, 2023 and 2033
Figure 49: Asia Pacific Market Attractiveness, by Country/Sub-region, 2023–2033
Figure 50: Asia Pacific Market Value Share, by Product Type, 2023 and 2033
Figure 51: Asia Pacific Market Attractiveness, by Product Type, 2023–2033
Figure 52: Asia Pacific Market Value Share, by Application Type, 2023 and 2033
Figure 53: Asia Pacific Market Attractiveness, by Application Type, 2023–2033
Figure 54: Asia Pacific Market Value Share, by End-user, 2023 and 2033
Figure 55: Asia Pacific Market Attractiveness, by End-user, 2023–2033
Figure 56: Latin America Market Size (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2023–2033
Figure 57: Latin America Market Value Share, by Country/Sub-region, 2023 and 2033
Figure 58: Latin America Market Attractiveness, by Country/Sub-region, 2023–2033
Figure 59: Latin America Market Value Share, by Product Type, 2023 and 2033
Figure 60: Latin America Market Attractiveness, by Product Type, 2023–2033
Figure 61: Latin America Market Value Share, by Application Type, 2023 and 2033
Figure 62: Latin America Market Attractiveness, by Application Type, 2023–2033
Figure 63: Latin America Market Value Share, by End-user, 2023 and 2033
Figure 64: Latin America Market Attractiveness, by End-user, 2023–2033
Figure 65: Middle East & Africa Market Size (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2023–2033
Figure 66: Middle East & Africa Market Value Share, by Country/Sub-region, 2023 and 2033
Figure 67: Middle East & Africa Market Attractiveness, by Country/Sub-region, 2023–2033
Figure 68: Middle East & Africa Market Value Share, by Product, 2023 and 2033
Figure 69: Middle East & Africa Market Attractiveness, by Product, 2023–2033
Figure 70: Middle East & Africa Market Value Share, by Application, 2023 and 2033
Figure 71: Middle East & Africa Market Attractiveness, by Application, 2023–2033
Figure 72: Middle East & Africa Market Value Share, by End-user, 2023 and 2033
Figure 73: Middle East & Africa Market Attractiveness, by End-user, 2023–2033
Figure 74: Thermo Fisher Scientific Inc. Revenue (US$ Bn) and Y-o-Y Growth (%), 2018–2022
Figure 75: Thermo Fisher Scientific Inc. Breakdown of Net Sales, by Region, 2022
Figure 76: Thermo Fisher Scientific Inc. Breakdown of Net Sales, by Business Segment, 2022
Figure 77: Thermo Fisher Scientific Inc. R&D Expense (US$ Mn) and Y-o-Y Growth (%), 2018–2022
Figure 78: GenScript Revenue (US$ Mn) and Y-o-Y Growth (%), 2018–2022
Figure 79: GenScript Breakdown of Net Sales, by Region, 2022
Figure 80: GenScript Breakdown of Net Sales, by Business Segment, 2022
Figure 81: GenScript R&D Expense (US$ Mn) and Selling and Distribution (US$ Mn), 2018–2022
Figure 82: Merck KGaA (Sigma Aldrich) Revenue (US$ Bn) and Y-o-Y Growth (%), 2018–2022
Figure 83: Merck KGaA (Sigma Aldrich) Breakdown of Net Sales, by Region, 2022
Figure 84: Merck KGaA (Sigma Aldrich) Breakdown of Net Sales, by Business Segment, 2022
Figure 85: Merck KGaA (Sigma Aldrich) Research & Development Market Share (%), by Business Segment, 2022
Figure 86: Agilent Technologies Breakdown of Net Sales, by Region, 2022
Figure 87: Agilent Technologies Breakdown of Net Sales (US$ Mn), by Segment, 2022
Figure 88: Agilent Technologies Revenue (US$ Mn) and Y-o-Y Growth (%), 2018–2022
Know thy Competitors
Competitive landscape highlights only certain players
Complete list available upon request
CRISPR and Cas Genes Market